Institute of Reproductive and Developmental Biology, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, UK; Department of Surgery and Cancer, Imperial College London, London, UK; Imperial College Healthcare NHS Trust, London, UK.
Institute of Reproductive and Developmental Biology, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, UK; Department of Surgery and Cancer, Imperial College London, London, UK; Imperial College Healthcare NHS Trust, London, UK.
Lancet Oncol. 2022 Aug;23(8):e385-e392. doi: 10.1016/S1470-2045(22)00191-7.
Local cervical treatment for squamous intraepithelial lesion (SIL) or cervical intraepithelial neoplasia (CIN) removes or ablates a cone-shaped or dome-shaped part of the cervix that contains abnormal cells. This Series paper introduces the 2022 terminology for cone dimensions after local conservative treatment for SIL, CIN, or early invasive cervical cancer. The terminology was prepared by the Nomenclature Committee of the European Society of Gynaecologic Oncology, the European Federation for Colposcopy, the International Federation of Cervical Pathology and Colposcopy, and the European Society of Pathology. Cone length should be tailored to the type of transformation zone. Treatment of SIL or CIN is associated with an increased risk of preterm birth, which escalates with increasing cone length. There is a lack of agreement regarding terms used to report excised specimen dimensions both intraoperatively and in the pathology laboratory. Consensus is needed to make studies addressing effectiveness and safety of SIL or CIN treatment comparable, and to facilitate their use to improve accuracy of antenatal surveillance and management. This Series paper summarises the current terminology through a review of existing literature, describes new terminology as agreed by a group of experts from international societies in the field of cervical cancer prevention and treatment, and recommends use of the new terminology that will facilitate communication between clinicians and foster more specific treatment guidelines that balance obstetrical harm against therapeutic effectiveness.
局部宫颈治疗用于治疗鳞状上皮内病变 (SIL) 或宫颈上皮内瘤变 (CIN),切除或消融含有异常细胞的宫颈锥形或穹顶状部分。本系列论文介绍了 2022 年 SIL、CIN 或早期浸润性宫颈癌局部保守治疗后宫颈锥切的术语。该术语由欧洲妇科肿瘤学会命名委员会、欧洲阴道镜学会、国际宫颈病理与阴道镜学会和欧洲病理学会制定。锥切长度应根据转化区的类型而定。SIL 或 CIN 的治疗与早产风险增加相关,随着锥切长度的增加,早产风险也会增加。目前,在手术中和病理实验室中报告切除标本尺寸的术语缺乏一致性。需要达成共识,使研究能够比较 SIL 或 CIN 治疗的有效性和安全性,并促进其使用,以提高产前监测和管理的准确性。本系列论文通过回顾现有文献,总结了当前的术语,并描述了来自宫颈癌预防和治疗领域国际学会的一组专家达成的新术语,建议使用新术语,以便临床医生之间的沟通,并制定更具体的治疗指南,在产科危害和治疗效果之间取得平衡。